Geneva, March 20 -- International Clinical Trials Registry received information related to the study (DRKS00038217) titled 'An open-label, mono center study to evaluate the feasibility of fecal microbiota transplantation in patients with immune-related enterocolitis' on Feb. 25.
Study Type: interventional
Study Design:
Allocation: N/A: single arm study
Masking: Open (masking not used)
Control: uncontrolled
Assignment: single
Study design purpose: treatment
Primary Sponsor: Universitatsspital Zurich
Condition:
Immune-related enterocolitis in patients with cancer undergoing immunotherapy
Intervention:
Group 1: Fecal Microbiota Transplantation (FMT)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 01/04/20...